European Society of Cardiology
Welcome to the European Society of Cardiology
 
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Our mission: to reduce the burden of cardiovascular disease in Europe
 

Valvular Heart Disease (Management of)

ESC Clinical Practice Guidelines

Topics:

Valvular Heart Diseases

Current versions available to download

Publication dateVersionsReferencesSize
2007Full TextEHJ 2007;28:230-268658 KB
 Pocket guidelines
 PdaDownload the PDA Version
 Slideset410 KB

Current translated versions available to download:

Authors

Alec Vahanian FESC (Chairperson), Helmut Baumgartner FESC, Jeroen Bax FESC, Eric Butchart EFESC, Robert Dion, Gerasimos Filippatos FESC, Frank A Flachskampf FESC, Roger Hall FESC, Bernard Iung FESC, Jaroslaw D Kasprzak FESC, Patrick Nataf, Pilar Tornos Mas FESC, Lucia Torracca, Arnold Wenink

Endorsed by:

Bookmark and Share

Table of contents: Full Text (ESC Clinical Practice Guidelines)

Introduction

Why do we need guidelines on valvular heart disease?, Contents of these guidelines, How to use these guidelines, Method of review, Definition of levels of recommendation

General comments

Patient evaluation, Clinical evaluation, Echocardiography, Fluoroscopy, Radionuclide angiography, Stress testing, Other non-invasive imaging techniques, Biomarkers, oronary angiography, Cardiac catheterization, Assessment of comorbidity, Endocarditis prophylaxis, Risk stratification

Aortic regurgitation

Introduction, Evaluation, Natural history, Results of surgery, Indications for surgery, Medical therapy,
Serial testing, Special patient populations

Aortic stenosis

Introduction, Evaluation, Natural history, Results of intervention, Indications for surgery,
Indications for balloon valvuloplasty, Medical therapy, Serial testing, Special patient populations

Mitral regurgitation

Organic mitral regurgitation, Evaluation, Natural history, Results of surgery, Indications for intervention,
Medical therapy, Serial testing, Ischaemic mitral regurgitation, Evaluation, Natural history, Results of surgery, Indications for surgery, Functional mitral regurgitation

Mitral stenosis

Introduction, Evaluation, Natural history, Results of intervention, Percutaneous balloon commissurotomy,
Surgery, Indications for intervention, Medical therapy, Serial testing, Special patient populations

Tricuspid disease

Tricuspid stenosis, Evaluation, Surgery, Percutaneous intervention, Indications for intervention,
Medical therapy, Tricuspid regurgitation, Evaluation, Natural history, Results of surgery, Indications for surgery, Medical therapy

Combined and multiple valve diseases

Prosthetic valves

Choice of prosthetic valve, Management after valve replacement, Baseline assessment and modalities of follow-up, Antithrombotic management, Management of valve thrombosis, Management of thrombo-embolism,
Management of haemolysis and paravalvular leak, Management of bioprosthetic failure, Heart failure

Management during non-cardiac surgery

Clinical predictors of increased perioperative cardiovascular risk, Preoperative clinical evaluation,
Specific valve lesions, Aortic stenosis, Mitral stenosis, Aortic regurgitation and mitral regurgitation,
Prosthetic valves, Endocarditis prophylaxis, Perioperative monitoring

Management during pregnancy

Cardiac risk of pregnancy, Evaluation of the pregnant patient with heart valve disease, Specific risks related to pregnancy, Native valve disease, Patients with prosthetic valves, Treatment, Aims, Methods,
Management strategy, Delivery

Previous versions

A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here